Hormonal Coc Spiro denied due to quantity / dose limits by Cigna?

Cigna's specific coverage criteria for hormonal coc spiro are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna May Impose Quantity Limits on Combined COC + Spironolactone

Quantity limit denials occur when the number of units, tablets, or days' supply prescribed exceeds what Cigna's plan allows per fill or per period. For this combination, a quantity limit denial may affect the hormonal contraceptive, the spironolactone, or both. Plans set quantity limits based on their interpretation of standard prescribing practice, and those limits do not always reflect the individualized dosing your prescriber has determined is clinically appropriate.

Quantity limit overrides are routinely granted when the prescriber documents the clinical rationale for the quantity prescribed. This type of denial is among the most straightforward to appeal successfully.

## Your Federal Appeal Rights

ACA Section 2719 requires internal appeal and independent external review for non-grandfathered plans. ERISA Section 503 applies to employer-sponsored plans. You have approximately four months from the final internal denial to request external review. Expedited review is available when a delay would harm your health.

## Appeal Process and Timeline

1. Identify the exact quantity limit applied — call Cigna or read the denial letter to learn the allowed quantity versus what was prescribed. 2. Ask your prescriber to submit a quantity limit exception request with clinical justification — this is often the fastest route. 3. File a written internal appeal if the exception is denied. 4. Request external review if the internal appeal fails.

## Documentation to Gather

• Prescribing rationale: A letter from your prescriber explaining why the prescribed quantity is medically necessary and what clinical factors require it.
• Diagnosis and severity documentation: Chart notes showing the condition being treated and its characteristics that drive the prescribing decision.
• FDA prescribing label reference: Confirm with your prescriber that the prescribed quantity is consistent with the FDA-approved prescribing label for each agent, and document that in the exception request.
• Prior quantity history: If you have previously been dispensed this quantity without clinical incident, document that history.

## Criteria-Mapping Structure

Obtain Cigna's quantity limit criteria from the plan documents or the denial letter. Map your documentation to each element:

| Quantity Limit Criterion | Supporting Evidence | |---|---| | Prescribed quantity exceeds standard limit | Prescriber letter explaining clinical rationale for quantity | | FDA label supports prescribed quantity | Prescriber attestation referencing label guidance | | No clinical alternative requiring lower quantity | Explanation of why standard quantity is insufficient |

Be precise: state the exact quantity prescribed, the plan limit, and the specific clinical reason the limit does not fit your case. Vague requests for "more medication" are routinely denied; specific clinical reasoning is routinely approved. Confirm the FDA-approved prescribing label dosing range with your prescriber before submitting.